Shares of Inhibitex (INHX) skyrocket - up 128% premarket - after reporting positive top-line...

|By:, SA News Editor

Shares of Inhibitex (INHX) skyrocket - up 128% premarket - after reporting positive top-line safety and antiviral data from an ongoing clinical trial of its hepatitis C treatment.